PMC:7074424 / 693-888
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"14","span":{"begin":40,"end":48},"obj":"Gene"}],"attributes":[{"id":"A14","pred":"tao:has_database_id","subj":"14","obj":"Gene:164045"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"id protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design pers"}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T16","span":{"begin":60,"end":64},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T15","span":{"begin":179,"end":183},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"id protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design pers"}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":3,"end":10},"obj":"Body_part"},{"id":"T5","span":{"begin":124,"end":132},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"id protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design pers"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T8","span":{"begin":3,"end":10},"obj":"Chemical"},{"id":"T9","span":{"begin":60,"end":64},"obj":"Chemical"},{"id":"T10","span":{"begin":124,"end":132},"obj":"Chemical"},{"id":"T11","span":{"begin":179,"end":183},"obj":"Chemical"}],"attributes":[{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"id protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design pers"}